| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $54.9M | +92.5% |
| SG&A Expense | $14.8M | +15.8% |
| Operating Income | -$69.6M | -64.8% |
| Income Tax | $0 | — |
| Net Income | -$64.7M | -58.1% |
| EPS (Basic) | -$2.74 | +1.8% |
| EPS (Diluted) | -$2.74 | +1.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.6M | -42.5% |
| Current Assets | $110.5M | +12.1% |
| Total Assets | $138.7M | +35.3% |
| Current Liabilities | $14.0M | +95.4% |
| Total Liabilities | $14.0M | +95.4% |
| Stockholders' Equity | $124.7M | +30.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$53.3M | -59.2% |
| Investing Cash Flow | -$43.3M | -98.8% |
| Financing Cash Flow | $85.0M | +20.8% |